Malignant Melanoma
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography plays a vital role in the staging and post-treatment monitoring of high-risk melanoma patients. This chapter will answer the common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in high-risk melanoma patients.